Brenus Pharma
Company Details
Status: Private
Employees: 11-50
Location:
Lyon, France
Type:
sample
Technology:
sample
sample
sample
About: Brenus Pharma is a pioneering clinical stage biotech aiming to prevent cancer recurrence, the main challenge for solid tumors - causing 10M deaths each year worldwide.
We developped a next-generation cancer treatment, thanks to our “off-the-shelf” therapeutic platform.
Our lead candidate is a proteomic-driven immunotherapy targetting colorectal cancer (CRC), the 2nd deadliest cancer worldwide.
- Our allogeneic platform generates therapeutics that efficiently educate the immune system, with more potent, diverse and novel targets than any existing therapies. (Characterized by advanced multiomics technologies)
- We overcome limitations of several technologies such as mRNA vaccines thanks to our enhanced immunogenicity and standardized GMP manufacturing: we keep control of costs and supply.
Awarded “Best Biotech Startup” in 2024 in France, we recently closed a $25M SERIES A to accelerate our clinical development.
We are currently envisaging clinical collaborations.
Brenus Pharma sets a new paradigm in oncology, by giving back to patients the ability to fight against their disease.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Brenus Pharma | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.